From Nasdaq: 2025-05-24 06:40:00

Three biotech stocks, Alnylam Pharmaceuticals (NASDAQ: ALNY), Axsome Therapeutics (NASDAQ: AXSM), and Summit Therapeutics (NASDAQ: SMMT), are gaining momentum and could see further growth according to Fool.com contributors. Alnylam Pharmaceuticals has seen a 23% increase in share price year to date and reported 28% revenue growth in Q1. Axsome Therapeutics earned FDA approval for therapies and has a strong late-stage pipeline. Summit Therapeutics has potential with its cancer treatment, ivonescimab, showing promising results in a recent clinical trial. Investors should consider these stocks for potential growth opportunities.



Read more at Nasdaq: 3 High-Flying Stocks That Could Soar Even More